A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia

NCT00629681 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

217

Enrollment

INDUSTRY

Sponsor class

Conditions

Painful Diabetic Neuropathy and Post Herpetic Neuralgia

Interventions

DRUG: Pregabalin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.